TRAF4 enhances osteosarcoma cell proliferation and invasion by Akt signaling pathway

Oncology Research

Volumn 22, Issue 1, 2014, Pages 21-28

  Yao, Weitao ^a   Wang, Xin ^a   Cai, Qiqing ^a   Gao, Songtao ^a   Wang, Jiaqiang ^a   Zhang, Peng ^a  

^a ZHENGZHOU UNIVERSITY   (China)

Author keywords

Akt signaling pathway; Cell invasion; Cell proliferation; Osteosarcoma; TRAF4

Indexed keywords

KI 67 ANTIGEN; PROTEIN KINASE B; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 4; ONCOPROTEIN;

ADULT; ARTICLE; BONE TISSUE; BREAST CARCINOMA; CANCER TISSUE; CELL INVASION; CELL PROLIFERATION; COLONY FORMATION; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; OSTEOSARCOMA CELL; OSTEOSARCOMA CELL LINE; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; U2OS CELL LINE; UPREGULATION; YOUNG ADULT; BONE; BONE TUMOR; CARCINOGENESIS; GENETICS; METABOLISM; METASTASIS; OSTEOSARCOMA; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; TRANSGENE; TUMOR CELL LINE; TUMOR INVASION;

BONE AND BONES; BONE NEOPLASMS; CARCINOGENESIS; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; ONCOGENE PROTEIN V-AKT; OSTEOSARCOMA; PHOSPHORYLATION; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 4; TRANSGENES;

EID: 84911207413     PISSN: 09650407     EISSN: 15553906     Source Type: Journal    
DOI: 10.3727/096504014X14077751730351     Document Type: Article

References (39)

1. Vijayamurugan, N.; Bakhshi, S. Review of management issues in relapsed osteosarcoma. Expert Rev. Anticancer 14: 151-161; 2014.
2. Bielack, S.; Carrle, D.; Hardes, J.; Schuck, A. Paulussen, M. Bone tumors in adolescents and young adults. Curr. Treat. Options Oncol. 9:67-80; 2008.
3. Harting, M. T.; Blakely, M. L. Management of osteosarcoma pulmonary metastases. Semin. Pediatr. Surg. 15:25-29; 2006.
4. Zwaga, T.; Bovee, J. V.; Kroon, H. M. Osteosarcoma of the femur with skip, lymph node, and lung metastases. Radiographics 28:277-283; 2008.
5. Arch, R. H.; Gedrich, R. W.; Thompson, C. B. Tumor necrosis factor receptor-associated factors (TRAFs) - A family of adapter proteins that regulates life and death. Gene Dev. 12:2821-2830; 1998.
6. Bradley, J. R.; Pober, J. S. Tumor necrosis factor receptorassociated factors (TRAFs). Oncogene 20:6482-6491; 2001.
7. Kedinger, V.; Rio, M. C. TRAF4, the unique family member. Adv. Exp. Med. Biol. 597:60-71; 2007.
8. Regnier, C. H.; Tomasetto, C.; Moog-Lutz, C.; Chenard, M. P.; Wendling, C.; Basset, P.; Rio, M. C. Presence of a new conserved domain in CART1, a novel member of the tumor necrosis factor receptor-associated protein family, which is expressed in breast carcinoma. J. Biol. Chem. 270:25715-25721; 1995.
9. Régnier, C. H.; Masson, R.; Kedinger, V.; Textoris, J.; Stoll, I.; Chenard, M.-P.; Dierich, A.; Tomasetto, C.; Rio, M.-C. Impaired neural tube closure, axial skeleton malformations, and tracheal ring disruption in TRAF4-deficient mice. Proc. Natl. Acad. Sci. USA 99:5585-5590; 2002.
10. Shiels, H.; Li, X.; Schumacker, P. T.; Maltepe, E.; Padrid, P. A.; Sperling, A.; Thompson, C. B.; Lindsten, T. TRAF4 deficiency leads to tracheal malformation with resulting alterations in air flow to the lungs. Am. J. Pathol. 157: 679-688; 2000.
11. Marinis, J. M.; Homer, C. R.; McDonald, C.; Abbott, D. W. A novel motif in the Crohn's disease susceptibility protein, NOD2, allows TRAF4 to down-regulate innate immune responses. J. Biol. Chem. 286:1938-1950; 2011.
12. Zepp, J. A.; Liu, C.; Qian, W.; Wu, L.; Gulen, M. F.; Kang, Z.; Li, X. Cutting edge: TNF receptor-associated factor 4 restricts IL-17-mediated pathology and signaling processes. J. Immunol. 189:33-37; 2012.
13. Abell, A. N.; Johnson, G. L. MEKK4 is an effector of the embryonic TRAF4 for JNK activation. J. Biol. Chem. 280: 35793-35796; 2005.
14. Camilleri-Broet, S.; Cremer, I.; Marmey, B.; Comperat, E.; Viguie, F.; Audouin, J.; Rio, M. C.; Fridman, W. H.; Sautes-Fridman, C.; Regnier, C. H. TRAF4 overexpression is a common characteristic of human carcinomas. Oncogene 26:142-147; 2006.
15. Zhang, X.; Wen, Z.; Mi, X. Expression and anti-apoptotic function of TRAF4 in human breast cancer MCF-7 cells. Oncol. Lett. 7:411-414; 2014.
16. Wang, X.; Jin, C.; Tang, Y.; Tang, L. Y.; Zhang, Y. E. Ubiquitination of tumor necrosis factor receptor-associated factor 4 (TRAF4) by smad ubiquitination regulatory factor 1 (Smurf1) regulates motility of breast epithelial and cancer cells. J. Biol. Chem. 288:21784-21792; 2013.
17. Rousseau, A.; McEwen, A. G.; Poussin-Courmontagne, P.; Rognan, D.; Nomine, Y.; Rio, M. C.; Tomasetto, C.; Alpy, F. TRAF4 is a novel phosphoinositide-binding protein modulating tight junctions and favoring cell migration. PLoS Biol. 11:e1001726; 2013.
18. Zhang, L.; Zhou, F.; Garcia de Vinuesa, A.; de Kruijf, E. M.; Mesker, W. E.; Hui, L.; Drabsch, Y.; Li, Y.; Bauer, A.; Rousseau, A.; Sheppard, K. A.; Mickanin, C.; Kuppen, P. J.; Lu, C. X.; Ten Dijke, P. TRAF4 promotes TGF-b receptor signaling and drives breast cancer metastasis. Mol. Cell 51: 559-572; 2013.
19. Yi, P.; Xia, W.; Wu, R.-C.; Lonard, D. M.; Hung, M.-C.; O'Malley, B. W. SRC-3 coactivator regulates cell resistance to cytotoxic stress via TRAF4-mediated p53 destabilization. Genes Dev. 27:274-287; 2013.
20. Li, W.; Peng, C.; Lee, M. H.; Lim, D.; Zhu, F.; Fu, Y.; Yang, G.; Sheng, Y.; Xiao, L.; Dong, X.; Ma, W.; Bode, A. M.; Cao, Y.; Dong, Z. TRAF4 is a critical molecule for Akt activation in lung cancer. Cancer Res. 73:6938-6950; 2013.
21. Shen, J.; Qiao, Y.; Ran, Z.; Wang, T. Different activation of TRAF4 and TRAF6 in inflammatory bowel disease. Mediat. Inflamm. 647936:28; 2013.
22. Schmittgen, T. D.; Livak, K. J. Analyzing real-time PCR data by the comparative CT method. Nat. Protoc. 3: 1101-1108; 2008.
23. Zhang, K.; Tian, F.; Zhang, Y.; Zhu, Q.; Xue, N.; Zhu, H.; Wang, H.; Guo, X. MACC1 is involved in the regulation of proliferation, colony formation, invasion ability, cell cycle distribution, apoptosis and tumorigenicity by altering Akt signaling pathway in human osteosarcoma. Tumour Biol. 35(3):2537-2548; 2014.
24. Geissmann, Q. OpenCFU, a new free and open-source software to count cell colonies and other circular objects. PLoS One 8:e54072; 2013.
25. Romero, Q.; Bendahl, P. O.; Klintman, M.; Loman, N.; Ingvar, C.; Ryden, L.; Rose, C.; Grabau, D.; Borgquist, S. Ki67 proliferation in core biopsies versus surgical samples - A model for neo-adjuvant breast cancer studies. BMC Cancer 11:341; 2011.
26. Hernández-Rodríguez, N. A.; Correa, E.; Sotelo, R.; Contreras-Paredes, A.; Gomez-Ruiz, C.; Green, L.; Mohar, A. Ki-67: A proliferative marker that may predict pulmonary metastases and mortality of primary osteosarcoma. Cancer Detect. Prev. 25:210-215; 2001.
27. Li, B.; Yang, Y.; Jiang, S.; Ni, B.; Chen, K.; Jiang, L. Adenovirus-mediated overexpression of BMP-9 inhibits human osteosarcoma cell growth and migration through downregulation of the PI3K/Akt pathway. Int. J Oncol. 41: 1809-1819; 2012.
28. Urruticoechea, A.; Smith, I. E.; Dowsett, M. Proliferation marker Ki-67 in early breast cancer. J. Clin. Oncol. 23: 7212-7220; 2005.
29. Brazil, D. P.; Park, J.; Hemmings, B. A. PKB binding proteins: Getting in on the Akt. Cell 111:293-303; 2002.
30. Manning, B. D.; Cantley, L. C. Akt/PKB signaling: Navigating downstream. Cell 129:1261-1274; 2007.
31. Liu, P.; Cheng, H.; Roberts, T. M.; Zhao, J. J. Targeting the phosphoinositide 3-kinase pathway in cancer. Nat. Rev. Drug Discov. 8:627-644; 2009.
32. Camilleri-Broet, S.; Cremer, I.; Marmey, B.; Comperat, E.; Viguie, F.; Audouin, J.; Rio, M. C.; Fridman, W. H.; Sautes-Fridman, C.; Regnier, C. H. TRAF4 overexpression is a common characteristic of human carcinomas. Oncogene 26:142-147; 2007.
33. Santisteban, M.; Reynolds, C.; Barr Fritcher, E. G.; Frost, M. H.; Vierkant, R. A.; Anderson, S. S.; Degnim, A. C.; Visscher, D. W.; Pankratz, V. S.; Hartmann, L. C. Ki67: A time-varying biomarker of risk of breast cancer in atypical hyperplasia. Breast Cancer Res. Tr. 121:431-437; 2010.
34. Longhi, A.; Errani, C.; De Paolis, M.; Mercuri, M.; Bacci, G. Primary bone osteosarcoma in the pediatric age: State of the art. Cancer Treat. Rev. 32:423-436; 2006.
35. Yamaguchi, H.; Wyckoff, J.; Condeelis, J. Cell migration in tumors. Curr. Opin. Cell Biol. 17:559-564; 2005.
36. Vivanco, I.; Sawyers, C. L. The phosphatidylinositol 3-kinase-akt pathway in human cancer. Nat. Rev. Cancer 2: 489-501; 2002.
37. Zhao, G.; Cai, C.; Yang, T.; Qiu, X.; Liao, B.; Li, W.; Ji, Z.; Zhao, J.; Zhao, H.; Guo, M.; Ma, Q.; Xiao, C.; Fan, Q.; Ma, B. MicroRNA-221 induces cell survival and cisplatin resistance through PI3K/Akt pathway in human osteosarcoma. Plos One 8:e53906; 2013.
38. Shukla, S.; MacLennan, G. T.; Hartman, D. J.; Fu, P.; Resnick, M. I.; Gupta, S. Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion. Int. J. Cancer 121:1424-1432; 2007.
39. Kim, D.; Kim, S.; Koh, H.; Yoon, S. O.; Chung, A. S.; Cho, K. S.; Chung, J. Akt/PKB promotes cancer cell invasion via increased motility and metalloproteinase production. FASEB J. 15:1953-1962; 2001.